Technical Analysis for FEMY - Femasys Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | -1.57% | |
| NR7 | Range Contraction | -1.57% | |
| Narrow Range Bar | Range Contraction | -1.57% | |
| Down 3 Days in a Row | Weakness | -1.57% | |
| Fell Below 20 DMA | Bearish | -3.10% | |
| Spinning Top | Other | -3.10% | |
| Bollinger Band Squeeze | Range Contraction | -3.10% | |
| Bollinger Band Squeeze | Range Contraction | -6.02% | |
| NR7 | Range Contraction | -6.02% | |
| Gapped Down | Weakness | -6.02% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Down 2 % | about 2 hours ago |
| Down 1% | about 2 hours ago |
| Possible NR7 | 3 days ago |
| 60 Minute Opening Range Breakdown | 3 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Femasys Inc. Description
Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc, a first and only non-surgical product for permanent birth control and FemaSeed, a first and only directed sperm delivery product for infertility treatment. Femasys’ FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Ultrasound Infertility Birth Control Fertility Medicine Assisted Reproductive Technology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.75 |
| 52 Week Low | 0.2479 |
| Average Volume | 433,019 |
| 200-Day Moving Average | 1.14 |
| 50-Day Moving Average | 1.50 |
| 20-Day Moving Average | 1.31 |
| 10-Day Moving Average | 1.32 |
| Average True Range | 0.11 |
| RSI (14) | 44.44 |
| ADX | 18.33 |
| +DI | 18.54 |
| -DI | 24.69 |
| Chandelier Exit (Long, 3 ATRs) | 1.19 |
| Chandelier Exit (Short, 3 ATRs) | 1.52 |
| Upper Bollinger Bands | 1.41 |
| Lower Bollinger Band | 1.20 |
| Percent B (%b) | 0.32 |
| BandWidth | 15.69 |
| MACD Line | -0.04 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0093 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.35 | ||||
| Resistance 3 (R3) | 1.34 | 1.32 | 1.33 | ||
| Resistance 2 (R2) | 1.32 | 1.30 | 1.32 | 1.33 | |
| Resistance 1 (R1) | 1.29 | 1.29 | 1.28 | 1.30 | 1.32 |
| Pivot Point | 1.27 | 1.27 | 1.26 | 1.27 | 1.27 |
| Support 1 (S1) | 1.24 | 1.25 | 1.23 | 1.25 | 1.22 |
| Support 2 (S2) | 1.22 | 1.24 | 1.22 | 1.21 | |
| Support 3 (S3) | 1.19 | 1.22 | 1.21 | ||
| Support 4 (S4) | 1.20 |
